NCT05894954 2026-02-18
EVANTHEA
Alzheimer's Prevention and Reversal Project, Inc.
Phase 3 Completed
Clinical Trials
14 trialsNCT06471660 2025-12-18
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
University of Oregon
Completed
NCT04971733 2025-06-10
A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
Eisai Inc.
Phase 1/2 Completed
NCT05328115 2025-01-31
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
Alzinova AB
Phase 1 Completed
NCT04313582 2024-07-16
SmartPrompt
Temple University
Phase NA Completed
NCT04315337 2024-07-16
VKI
Temple University
Phase NA Completed
NCT04531956 2024-01-23
S-DeciDeD
Maastricht University
Phase NA Completed
NCT03384043 2020-07-08
Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease
Baylor University
Phase NA Completed
NCT03246269 2018-05-31
MoCA-Norm
University Hospital, Basel, Switzerland
Completed
NCT00348140 2017-09-05
REFLECT-3
GlaxoSmithKline
Phase 3 Completed
NCT02859207 2017-06-08
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Eisai Inc.
Phase 1 Completed
NCT00428090 2017-05-19
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
GlaxoSmithKline
Phase 3 Completed
NCT02187276 2014-09-12
The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia
Federal University of Minas Gerais
Completed
NCT00411580 2013-03-29
Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)
Novartis
Phase 1 Completed